NOKOMIS, Fla. & SUNNYVALE, Calif.--(BUSINESS WIRE)--Rainbow BioSciences, a subsidiary of Rainbow Coral Corp (OTCBB: RBCC) has executed a Letter Of Intent (“LOI”) to advance Amarantus BioSciences, Inc.’s (OTCBB: AMBS) Parkinson’s disease program, comprised of an early detection diagnostic blood test and a disease-modifying protein drug candidate.
